Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity.

Sivick KE, Desbien AL, Glickman LH, Reiner GL, Corrales L, Surh NH, Hudson TE, Vu UT, Francica BJ, Banda T, Katibah GE, Kanne DB, Leong JJ, Metchette K, Bruml JR, Ndubaku CO, McKenna JM, Feng Y, Zheng L, Bender SL, Cho CY, Leong ML, van Elsas A, Dubensky TW Jr, McWhirter SM.

Cell Rep. 2019 Oct 15;29(3):785-789. doi: 10.1016/j.celrep.2019.09.089. No abstract available.

2.

Harnessing the anti-cancer natural product nimbolide for targeted protein degradation.

Spradlin JN, Hu X, Ward CC, Brittain SM, Jones MD, Ou L, To M, Proudfoot A, Ornelas E, Woldegiorgis M, Olzmann JA, Bussiere DE, Thomas JR, Tallarico JA, McKenna JM, Schirle M, Maimone TJ, Nomura DK.

Nat Chem Biol. 2019 Jul;15(7):747-755. doi: 10.1038/s41589-019-0304-8. Epub 2019 Jun 17.

3.

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.

Ward CC, Kleinman JI, Brittain SM, Lee PS, Chung CYS, Kim K, Petri Y, Thomas JR, Tallarico JA, McKenna JM, Schirle M, Nomura DK.

ACS Chem Biol. 2019 Nov 15;14(11):2430-2440. doi: 10.1021/acschembio.8b01083. Epub 2019 May 13.

PMID:
31059647
4.

Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity.

Sivick KE, Desbien AL, Glickman LH, Reiner GL, Corrales L, Surh NH, Hudson TE, Vu UT, Francica BJ, Banda T, Katibah GE, Kanne DB, Leong JJ, Metchette K, Bruml JR, Ndubaku CO, McKenna JM, Feng Y, Zheng L, Bender SL, Cho CY, Leong ML, van Elsas A, Dubensky TW Jr, McWhirter SM.

Cell Rep. 2018 Dec 11;25(11):3074-3085.e5. doi: 10.1016/j.celrep.2018.11.047. Erratum in: Cell Rep. 2019 Oct 15;29(3):785-789.

5.

Chiral Diaryliodonium Phosphate Enables Light Driven Diastereoselective α-C(sp3)-H Acetalization.

Ye B, Zhao J, Zhao K, McKenna JM, Toste FD.

J Am Chem Soc. 2018 Jul 5;140(26):8350-8356. doi: 10.1021/jacs.8b05962. Epub 2018 Jun 25.

6.

The development and mechanistic investigation of a palladium-catalyzed 1,3-arylfluorination of chromenes.

Thornbury RT, Saini V, Fernandes TA, Santiago CB, Talbot EPA, Sigman MS, McKenna JM, Toste FD.

Chem Sci. 2017 Apr 1;8(4):2890-2897. doi: 10.1039/c6sc05102b. Epub 2017 Feb 9.

7.

α- and α'-Lithiation-Electrophile Trapping of N-Thiopivaloyl and N-tert-Butoxythiocarbonyl α-Substituted Azetidines: Rationalization of the Regiodivergence Using NMR and Computation.

Jackson KE, Mortimer CL, Odell B, McKenna JM, Claridge TD, Paton RS, Hodgson DM.

J Org Chem. 2015 Oct 16;80(20):9838-46. doi: 10.1021/acs.joc.5b01804. Epub 2015 Sep 24.

8.

Amine protection/α-activation with the tert-butoxythiocarbonyl group: application to azetidine lithiation-electrophilic substitution.

Hodgson DM, Mortimer CL, McKenna JM.

Org Lett. 2015 Jan 16;17(2):330-3. doi: 10.1021/ol503441d. Epub 2014 Dec 23.

PMID:
25535850
9.

HOBS methods for enhancing resolution and sensitivity in small DNA oligonucleotide NMR studies.

McKenna JM, Parkinson JA.

Magn Reson Chem. 2015 Apr;53(4):249-55. doi: 10.1002/mrc.4182. Epub 2014 Oct 29.

10.

Gold Catalysed Redox Synthesis of Imidazo[1,2-a]pyridine using Pyridine N-Oxide and Alkynes.

Talbot EP, Richardson M, McKenna JM, Toste FD.

Adv Synth Catal. 2014 Mar 10;356(4):687-691.

11.

Asymmetric palladium-catalyzed directed intermolecular fluoroarylation of styrenes.

Talbot EP, Fernandes Tde A, McKenna JM, Toste FD.

J Am Chem Soc. 2014 Mar 19;136(11):4101-4. doi: 10.1021/ja412881j. Epub 2014 Mar 11.

12.

Kinetics of the interaction of myo1c with phosphoinositides.

McKenna JM, Ostap EM.

J Biol Chem. 2009 Oct 16;284(42):28650-9. doi: 10.1074/jbc.M109.049791. Epub 2009 Aug 25.

13.

Effect of effort pain after upper abdominal surgery on two independent measures of respiratory function.

Kimball WR, Carwood CM, Chang Y, McKenna JM, Peters LE, Ballantyne JC.

J Clin Anesth. 2008 May;20(3):200-5. doi: 10.1016/j.jclinane.2007.10.009.

PMID:
18502364
14.

An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors.

McKenna JM, Halley F, Souness JE, McLay IM, Pickett SD, Collis AJ, Page K, Ahmed I.

J Med Chem. 2002 May 23;45(11):2173-84.

PMID:
12014955
15.

Conscious-sedation analgesia during craniotomy for intractable epilepsy: a review of 354 consecutive cases.

Archer DP, McKenna JM, Morin L, Ravussin P.

Can J Anaesth. 1988 Jul;35(4):338-44.

PMID:
3402010
16.

Fatal pancytopenia associated with the use of captopril.

Gavras I, Graff LG, Rose BD, McKenna JM, Brunner HR, Gavras H.

Ann Intern Med. 1981 Jan;94(1):58-9. No abstract available.

PMID:
7004300
17.

Diagnostic value of carcinoembryonic antigen in exudative pleural effusions.

McKenna JM, Chandrasekhar AJ, Henkin RE.

Chest. 1980 Oct;78(4):587-90.

PMID:
7418482
18.

Assessment of cerebral damage during open-heart surgery. A new experimental model.

Taylor KM, Devlin BJ, Mittra SM, Gillan JG, Brannan JJ, McKenna JM.

Scand J Thorac Cardiovasc Surg. 1980;14(2):197-203.

PMID:
7433939
19.

Ultrastructural identification of mast cells obtained from human bronchial lumens.

Ts'ao C, Patterson R, McKenna JM, Suszko IM.

J Allergy Clin Immunol. 1977 Apr;59(4):320-6.

PMID:
850021
20.
21.

Living histamine-containing cells from the bronchial lumens of humans. Description and comparison of histamine content with cells of rhesus monkeys.

Patterson R, McKenna JM, Suszko IM, Solliday NH, Pruzansky JJ, Roberts M, Kehoe TJ.

J Clin Invest. 1977 Feb;59(2):217-25.

22.

Proceedings: The use of low level electrical current for enhancement of tissue healing.

Rowley BA, McKenna JM, Wolcott LE.

Biomed Sci Instrum. 1974 Apr;10:111-4. No abstract available.

PMID:
4824223
23.

The influence of electrical current on an infecting microorganism in wounds.

Rowley BA, McKenna JM, Chase GR, Wolcott LE.

Ann N Y Acad Sci. 1974;238:543-51. No abstract available.

PMID:
4216282
24.

The replication of poliovirus in primary kidney cell cultures of thirteen-lined ground squirrels.

McKenna JM, Shuck KM, Cashon GW.

Proc Soc Exp Biol Med. 1971 Nov;138(2):619-25. No abstract available.

PMID:
4330236
26.

Pasteurella infection in irradiated hamsters.

McKenna JM, South FE, Musacchia XJ.

Lab Anim Care. 1970 Jun;20(3):443-6. No abstract available.

PMID:
4247040
27.

Hypothermia, radiation, and the immune response.

Yin E, McKenna JM, Musacchia XJ.

Proc Soc Exp Biol Med. 1970 Apr;133(4):1207-11. No abstract available.

PMID:
5440408
28.

Immunologic studies of a spontaneous syngeneic tumor-host system. I. The role of immune mechanisms in tumor transplants in the syngeneic host.

Abdou NI, McKenna JM.

Int Arch Allergy Appl Immunol. 1969;35(1):20-34. No abstract available.

PMID:
4975392
29.

Antibody formation in hibernating ground squirrels (Citrellus tridecemlineatus).

McKenna JM, Musacchia XJ.

Proc Soc Exp Biol Med. 1968 Dec;129(3):720-4. No abstract available.

PMID:
5725083
30.

Immunologic studies of a spontaneous syngeneic tumor-host system. II. Specific immune tolerance and adoptive tolerance by thymic grafts.

Abdou NI, McKenna JM.

Int Arch Allergy Appl Immunol. 1968;34(6):589-96. No abstract available.

PMID:
5759678
31.

Studies on the photooxidation of manganese by isolated chloroplasts.

McKenna JM, Bishop NI.

Biochim Biophys Acta. 1967 Mar 8;131(2):339-49. No abstract available.

PMID:
6049484
32.

Induction of neoantigen (G) in human amnion ("WISH") cells by herpes virus A.

McKenna JM, Davis FE, Prier JE, Kleger B.

Nature. 1966 Dec 31;212(5070):1602-3. No abstract available.

PMID:
21108524
33.

Studies on the antigens of human tumors. II. Demonstration of a soluble specific antigen (G) in cell lines derived from malignant human tissue.

McKenna JM, Sanderson RP, Davis FE, Blakemore WS.

Cancer Res. 1966 May;26(5):984-9. No abstract available.

34.

Antigenic differences among sublines of the KB cell line.

McKenna JM, Lazarus H, Foley GE.

Exp Cell Res. 1966 Mar;41(3):609-13. No abstract available.

PMID:
4952047
35.

Some immunologic aspects of canine neoplasms.

McKenna JM, Prier JE.

Cancer Res. 1966 Jan;26(1):137-42. No abstract available.

36.

CYTOTOXIC ACTIVITY COMPARED WITH PHOTOMETRIC MEASUREMENTS OF SELECTED ALKYLATING AGENTS.

SANDERSON RP, MCKENNA JM, BLAKEMORE WS.

Nature. 1965 Jan 30;205:479-81. No abstract available.

PMID:
14265292
37.

Role of immune mechanisms in the transplantability of an isologous murine lymphatic leukemia.

Abdou NI, McKenna JM, Blakemore WS.

Surg Forum. 1965;16:231-3. No abstract available.

PMID:
5835151
38.

COMMON ANTIGENS BETWEEN HELA CELLS AND SOME HUMAN MALIGNANT TISSUES.

BLAKEMORE WS, MCKENNA JM.

Surgery. 1964 Oct;56:628-34. No abstract available.

PMID:
14210173
39.

STUDIES OF THE ANTIGENS OF HUMAN TUMORS. I. DEMONSTRATION OF A SOLUBLE SPECIFIC ANTIGEN IN HELA CELLS AND SOME HUMAN TUMORS.

MCKENNA JM, SANDERSON RP, BLAKEMORE WS.

Cancer Res. 1964 May;24:754-62. No abstract available.

40.

Antigenic distinction of human tumors.

BLAKEMORE WS, McKENNA JM.

Acta Unio Int Contra Cancrum. 1963;19:151-3. No abstract available.

PMID:
13971476
41.

Antibodies reactive with antigens derived from HeLa and J111 in patients with malignancies.

BLAKEMORE WS, McKENNA JM.

Surgery. 1962 Jul;52:213-9. No abstract available.

PMID:
13869769
42.

Extraction of Distinctive Antigens from Neoplastic Tissue.

McKenna JM, Sanderson RP, Blakemore WS.

Science. 1962 Feb 2;135(3501):370-1.

PMID:
17782631
43.

STUDIES ON ANTIBODY FORMATION BY PERITONEAL EXUDATE CELLS IN VITRO.

McKenna JM, Stevens KM.

J Exp Med. 1960 Mar 31;111(4):573-600.

44.

Perphenazine (trilafon) and chlorpromazine in experimental shock.

ROTH FE, McKENNA JM, GOVIER WM.

Proc Soc Exp Biol Med. 1958 Oct;99(1):157-60. No abstract available.

PMID:
13601798
45.

Studies on antibody synthesis initiated in vitro.

STEVENS KM, McKENNA JM.

J Exp Med. 1958 Apr 1;107(4):537-59.

46.

An hemagglutination test for titration of antibodies to polioviruses.

McKENNA JM, ZUSCHEK F, FRANKEL JW.

Proc Soc Exp Biol Med. 1958 Jan;97(1):160-3. No abstract available.

PMID:
13518208
47.

A stable preparation of antigen-sensitized erythrocytes.

MCKENNA JM.

Proc Soc Exp Biol Med. 1957 Jul;95(3):591-3. No abstract available.

PMID:
13453518
48.

The early phase of the antibody response.

MCKENNA JM, STEVENS KM.

J Immunol. 1957 May;78(5):311-7. No abstract available.

PMID:
13449320
49.

Antibody production in a completely in vitro system.

STEVENS KM, MCKENNA JM.

Nature. 1957 Apr 27;179(4565):870-1. No abstract available.

PMID:
13430723
50.

Comparative study of the physiological effects of x-irradiation and resistance to traumatic shock.

MCKENNA JM, ZWEIFACH BW.

Radiat Res. 1957 Feb;6(2):126-36. No abstract available.

PMID:
13420338

Supplemental Content

Loading ...
Support Center